Michel Lanteri-Minet Selected Research

Eye Pain

11/2022	Phantom vision after eye removal: prevalence, features and related risk factors.
8/2021	Phantom eye pain: a multicentric study in 100 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Lanteri-Minet Research Topics

Disease

16	Migraine Disorders (Migraine) 09/2022 - 01/2006
7	Headache (Headaches) 01/2022 - 04/2007
6	Pain (Aches) 09/2022 - 01/2018
2	Eye Pain 11/2022 - 08/2021
2	Uveal melanoma 11/2022 - 08/2021
2	Chronic Pain 09/2022 - 01/2022
2	Neuralgia (Stump Neuralgia) 01/2022 - 09/2019
2	Secondary Headache Disorders 12/2016 - 04/2009
2	Cluster Headache (Cluster Headaches) 01/2015 - 04/2010
2	Prescription Drug Overuse 04/2009 - 08/2006
1	Knee Osteoarthritis 09/2022
1	Nociceptive Pain 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	COVID-19 01/2022
1	Fibromyalgia (Fibrositis) 01/2022
1	Complex Regional Pain Syndromes 01/2022
1	Phantom Limb (Phantom Limbs) 08/2021
1	Glaucoma 08/2021
1	Retinal Detachment (Retinal Detachments) 08/2021
1	Endophthalmitis (Ophthalmia) 08/2021
1	Wounds and Injuries (Trauma) 08/2021
1	Neoplasms (Cancer) 09/2019
1	Hyperalgesia 11/2018
1	Ganglion Cysts (Ganglion) 01/2015
1	Trigeminal Neuralgia (Tic Douloureux) 04/2014
1	Substance-Related Disorders (Drug Abuse) 11/2010
1	Nervous System Diseases (Neurological Disorders) 11/2007
1	Paralysis (Palsy) 04/2007
1	Headache Disorders (Headache Syndromes) 08/2006

Drug/Important Bio-Agent (IBA)

5	erenumabIBA 01/2022 - 01/2018
5	Pharmaceutical PreparationsIBA 10/2020 - 04/2009
3	Calcitonin Gene-Related PeptideIBA 01/2022 - 01/2018
3	Tryptamines (Triptans)IBA 12/2016 - 11/2007
2	Monoclonal AntibodiesIBA 01/2022 - 01/2018
2	Opioid Analgesics (Opioids)IBA 01/2022 - 12/2016
2	galcanezumabIBA 10/2020 - 01/2018
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2018 - 01/2018
2	Topiramate (Topamax)FDA LinkGeneric 11/2018 - 12/2007
2	Analgesics (Analgesic Drugs)IBA 12/2016 - 04/2009
2	Biological ProductsIBA 11/2010 - 04/2007
1	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2022
1	eptinezumabIBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 08/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2019
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 09/2019
1	Acid Sensing Ion ChannelsIBA 11/2018
1	Amiloride (Midamor)FDA LinkGeneric 11/2018
1	Protons (Proton)IBA 11/2018
1	Sumatriptan (Imigran)FDA LinkGeneric 11/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	BarbituratesIBA 11/2010
1	Opiate AlkaloidsIBA 11/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2007
1	naratriptan FDA LinkGeneric 11/2007
1	almotriptan (Axert)FDA Link 01/2006

Therapy/Procedure

5	Therapeutics 10/2021 - 01/2006
1	Proton Therapy 11/2022
1	Pain Management 01/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	Surgical Amputation (Amputations) 08/2021
1	Injections 11/2018
1	Neurosurgical Procedures 01/2018
1	Craniotomy 01/2018
1	Operative Surgical Procedures 01/2015
1	Microvascular Decompression Surgery 01/2015
1	Salvage Therapy 04/2014
1	Deep Brain Stimulation 04/2010
1	Electrodes (Electrode) 04/2010